Cargando…
Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood–Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion
Recombinant tissue plasminogen activator (rt-PA) is used to treat acute ischemic stroke but is only effective if administered within 4.5 h after stroke onset. Delayed rt-PA treatment causes blood-brain barrier (BBB) disruption and hemorrhagic transformation. The compound 2-(-2-benzofuranyl)-2-imidaz...
Autores principales: | Zhang, Linlei, Xu, Shasha, Wu, Xiaoxiao, Chen, Jiaou, Guo, Xiaoling, Cao, Yungang, Zhang, Zheng, Yan, Jueyue, Cheng, Jianhua, Han, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303334/ https://www.ncbi.nlm.nih.gov/pubmed/32595494 http://dx.doi.org/10.3389/fphar.2020.00801 |
Ejemplares similares
-
Protective Effects of the Soluble Epoxide Hydrolase Inhibitor 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea in a Rat Model of Permanent Middle Cerebral Artery Occlusion
por: Zhang, Linlei, et al.
Publicado: (2020) -
Bis(triphenylphosphoranylidene)ammonium iodide
por: Beckett, Michael A., et al.
Publicado: (2010) -
Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site
por: Kimura, Atsuko, et al.
Publicado: (2009) -
2-Imidazoline Nitroxide Derivatives of Cymantrene
por: Maryunina, Kseniya, et al.
Publicado: (2022) -
Imidazoline-I2 PET Tracers in Neuroimaging
por: Parker, Christine A., et al.
Publicado: (2023)